Artemid supports FGN’s growth strategy
Artemid co-arranged the refinancing of the existing senior indebtedness to support FGN in its external growth strategy.
Founded in 2018, Fysiogroep Nederland (‘FGN’) is a leading provider of physiotherapy and speech therapy services in the Netherlands. The Group operates a broad network of around 150 physiotherapy and 90 speech therapy practices across the country.
FGN offers a comprehensive range of standard and specialized care services, and benefits from a solid and recurring revenue base driven by agreements with health insurers. The Group is actively consolidating a fragmented market through an ambitious buy-and-build strategy, positioning itself as a clear market leader.
This is Artemid’s second investment in the Benelux region, illustrating its pan-European commitment to supporting high-quality companies with solid fundamentals and strong growth trajectories.
This transaction demonstrates Artemid’s ambition to support transactions across Europe, with a particular focus on the DACH market, which remains central to its investment strategy.
The funds of the Artemid range are managed by the asset management company CAPZA and advised by Artemid SAS, which is a subsidiary of CAPZA and has financial investment advisor status (CIF in France). Artemid SAS is registered by the Orias under the number 14003497 since the 05/28/2014.
This document is aimed solely at the media and is for information purposes only. The opinions expressed here are the views of the author and do not constitute investment advice. This is not a recommendation to purchase, sell or subscribe to financial instruments, an offer to sell investment funds or an offer of financial services. This press release is as dated. They do not necessarily represent the views of any company within the AXA Investment Managers Group and may be subject to change without notice. This does not constitute a Financial Promotion. This is for information purposes only. No financial decisions should be made on the basis of the information provided. Past performance is not necessarily representative of future results: performance is not constant over time and the value of investments may fall as well as rise.
-
17Jul’ 2026CAPZA Transition exits Arlettie and renews its support through ArtemidCAPZA Transition exits Arlettie following a successful partnership that supported the company’s growth and international development.Read more -
3Jul’ 2026Artemid supports Lauralu in its growth strategyArtemid is supporting Eurazeo’s acquisition of Lauralu and accompanying the group in its next phase of growth.Read more -
24Mar’ 2026Artemid supports Only creative entrepreneurs in its growth strategyArtemid provides a senior debt financing to support Only’s buy-and-build strategy.Read more -
12Jan’ 2026Artemid completes first deal in ItalyArtemid participates in a senior debt financing to support BV Tech in its new phase of growth.Read more